Filing Analysis
Accuray Incorporated has released its financial results for the fourth quarter and the full fiscal year ended June 30, 2026. The filing includes a press release and an investor presentation regarding the company's operational and financial performance.
📋 Key Facts
- Reported financial results for Q4 and Fiscal Year 2026 on August 19, 2026.
- Fiscal year ended June 30, 2026.
- The company provided an earnings call presentation (Exhibit 99.2) for analysts and investors.
- Information was furnished under Item 2.02 and Item 7.01 of Form 8-K.
Accuray Inc. has been downgraded from the Nasdaq Global Select Market to the Nasdaq Capital Market and has been granted a 180-day extension to regain compliance with the $1.00 minimum bid price requirement.
🚩 Red Flags
- Downgrade in market tier (Global Select to Capital Market) indicates declining liquidity or market capitalization/valuation concerns.
- Failure to meet the $1.00 minimum bid price requirement is a precursor to potential delisting.
- The 180-day compliance window creates significant regulatory and valuation uncertainty.
📋 Key Facts
- Effective August 6, 2026, common stock transferred from Nasdaq Global Select Market to Nasdaq Capital Market.
- The company has been granted a 180-day period (until February 1, 2027) to meet the $1.00 minimum bid price requirement.
- Ticker symbol 'ARAY' remains unchanged.
Accuray Incorporated announced the full repayment and retirement of its 3.75% Convertible Senior Notes due 2026. The company paid off the remaining principal and accrued interest, effectively discharging the associated Indenture.
📋 Key Facts
- Repayment date: June 1, 2026
- Principal amount repaid: $18,000,000
- Accrued and unpaid interest paid: $337,500
- Notes were originally issued on May 13, 2021
- The Indenture with The Bank of New York Mellon Trust Company, N.A. has been satisfied and discharged
Accuray Incorporated reported its third quarter fiscal 2026 financial results and announced the withdrawal of its previously issued financial guidance for the full fiscal year 2026. The company also furnished an investor presentation for upcoming analyst and investor meetings.
🚩 Red Flags
- Withdrawal of fiscal year 2026 financial guidance suggests significant operational uncertainty or a material downward shift in performance expectations.
📋 Key Facts
- Financial results for the third quarter ended March 31, 2026, were released on May 6, 2026.
- The company officially withdrew its financial guidance for fiscal year 2026.
- Item 2.02 and Item 7.01 were used to furnish the press release and earnings presentation.
- The filing was signed by Ali Pervaiz, Senior Vice President & Chief Financial Officer.
Accuray Incorporated announced that Leonel Peralta, Senior Vice President and Chief Operations Officer, departed from the company effective April 26, 2026. The company stated the resignation was not the result of any disagreement regarding operations, policies, or practices.
🚩 Red Flags
- Departure of a key C-suite executive (COO) responsible for operations.
📋 Key Facts
- Leonel Peralta resigned as SVP and Chief Operations Officer effective April 26, 2026.
- The departure was reported under Item 5.02 of Form 8-K.
- The company explicitly noted no disagreements with the Board or management regarding company matters.
Accuray Incorporated amended its consulting agreement with Dedication Capital, LLC, an affiliate of director Steven F. Mayer, to reduce cash compensation by 50% while accelerating the vesting of nearly 1 million shares. The amendment extends the consulting term to October 31, 2026, and is expected to generate approximately $362,500 in cash savings.
🚩 Red Flags
- Related-party transaction involving an affiliate of a sitting board member.
- Significant acceleration of equity vesting (916,336 shares plus all PSAs) occurring simultaneously with cash fee reductions.
📋 Key Facts
- Amendment to Consulting Agreement with Dedication Capital, LLC (affiliate of Director Steven F. Mayer) signed April 1, 2026.
- Base Consulting Fee and minimum cash incentive awards for FY2026 and Q1 FY2027 reduced by 50%.
- Time-based vesting satisfied immediately for 916,336 Initial Restricted Shares and 100% of Performance Stock Awards (PSAs).
- Consulting term extended to October 31, 2026, with remaining 333,004 shares to vest at that time.
- Company expects at least $362,500 in cash savings from the reduction in fees.
Accuray Incorporated announced the appointment of Paul Miele as Senior Vice President and Chief Commercial Officer, effective April 6, 2026. The announcement was disclosed via a press release furnished under Regulation FD.
📋 Key Facts
- Paul Miele appointed as SVP, Chief Commercial Officer effective April 6, 2026.
- The disclosure was made under Item 7.01 (Regulation FD Disclosure).
- The filing includes a press release as Exhibit 99.1.
Accuray Incorporated finalized a separation agreement with Sandeep Chalke, Senior Vice President and Chief Commercial Officer, following his previously disclosed departure effective March 31, 2026. The agreement outlines severance benefits including a cash payment of $459,000 and accelerated equity vesting.
📋 Key Facts
- Sandeep Chalke, SVP and Chief Commercial Officer, will depart the company on March 31, 2026.
- The separation agreement was executed on March 13, 2026.
- Mr. Chalke will receive a lump sum payment of $459,000, equivalent to 12 months of his annual base salary.
- Equity grants scheduled to vest on May 31, 2026, will be accelerated; all subsequent equity is forfeited.
- A pro-rated bonus for fiscal year 2026 will be paid at the same time as other executive bonuses.
Accuray Incorporated has released an updated investor presentation corresponding to its Fiscal 2026 Second Quarter earnings. The filing is a standard disclosure under Item 7.01 regarding Regulation FD.
📋 Key Facts
- Company posted an updated investor presentation on its website on February 17, 2026.
- The presentation relates to the Fiscal 2026 Second Quarter earnings call.
- Information is provided under Item 7.01 (Regulation FD Disclosure) and is not considered 'filed' for purposes of Section 18 liability.
Accuray Inc. has announced that its previously issued financial statements for fiscal year 2025 and the first quarter of fiscal year 2026 should no longer be relied upon due to errors in the disclosure of Remaining Performance Obligations (RPO). The company identified material weaknesses in its internal control over financial reporting (ICFR) and disclosure controls and procedures (DCP) related to ASC 606 implementation.
🚩 Red Flags
- Restatement of previously issued financial statements (Item 4.02).
- Admission of material weaknesses in Internal Control Over Financial Reporting (ICFR) and Disclosure Controls and Procedures (DCP).
- Potential for delayed filings due to the need for amended reports.
📋 Key Facts
- Errors identified in Note 2 (Revenue) regarding the disclosure of Remaining Performance Obligations (RPO).
- Affected filings include: Form 10-K for fiscal year ended June 30, 2025; Form 10-Qs for fiscal year 2025 and the quarter ended September 30, 2025.
- The error is isolated to a footnote disclosure; no impact on Balance Sheets, Income Statements, or Cash Flow statements is expected.
- Errors stemmed from incorrect methodology in determining if open system/upgrade sales orders meet RPO definitions under ASC 606.
- Material weaknesses identified in ICFR and DCP regarding review of footnote schedules and analysis of GAAP-required information.
- The company expects to file amended reports (10-K/A and 10-Q/A) within the five-day extension period permitted by Rule 12b-25.
Accuray Inc. received a notice from Nasdaq stating it is no longer in compliance with the $1 minimum bid price rule (Rule 5550(a)(2)). The company has been granted a 180-day compliance period ending August 3, 2026, to regain compliance.
🚩 Red Flags
- Delisting notice from Nasdaq
- Potential for a mandatory reverse stock split to meet listing requirements
- Stock price has been consistently below $1.00 (penny stock territory)
📋 Key Facts
- Received notice from Nasdaq on February 2, 2026, regarding non-compliance with the Bid Price Rule (Rule 5550(a)(2)).
- The deficiency is based on the closing bid price being below $1.00 for the last 30 consecutive business days.
- A 180-day compliance period has been granted, expiring August 3, 2026.
- To regain compliance, shares must maintain a minimum $1.00 closing bid price for at least 10 consecutive business days during the period.
- Failure to cure may lead to delisting or a requirement to transfer to the Nasdaq Capital Market via a potential reverse stock split.
Accuray Inc. has filed an 8-K to announce its financial results for the second quarter of fiscal year 2026, which ended on December 31, 2025.
📋 Key Facts
- Reported date: February 4, 2026
- Reporting period: Second Quarter ended December 31, 2025
- The filing includes a press release (Exhibit 99.1) and an earnings call presentation (Exhibit 99.2)
- Information is furnished under Item 2.02 and Item 7.01 of Form 8-K
Accuray Inc. announced the resignation of Sandeep Chalke from his position as Senior Vice President and Chief Commercial Officer, effective March 31, 2026.
🚩 Red Flags
- Departure of a high-level executive (Chief Commercial Officer) can sometimes signal shifts in commercial strategy or internal friction, though this is mitigated by the explicit 'no disagreement' clause.
📋 Key Facts
- Sandeep Chalke is resigning as SVP and Chief Commercial Officer.
- The resignation was communicated on January 15, 2026.
- The resignation becomes effective on March 31, 2026.
- The company explicitly stated the resignation is not due to any disagreement with the Company or its Board regarding operations, policies, or practices.
Accuray Incorporated announced the retirement of Class II director Byron C. Scott from the Board and all committees, effective December 31, 2025.
📋 Key Facts
- Byron C. Scott is retiring as a Class II director on December 31, 2025.
- The departure includes his resignation from all Board committees.
- The Company explicitly stated the retirement is not due to any disagreement with the Company or its operations, policies, or practices.
Accuray Inc. has entered into significant amendments to its existing financing agreement and issued a massive volume of warrants to lenders, including 'Penny Warrants' with an exercise price of $0.01 per share. Additionally, the company announced a major restructuring plan involving a 15% global workforce reduction.
🚩 Red Flags
- Extremely dilutive 'Penny Warrants' at $0.01 exercise price suggest severe liquidity distress or lender leverage.
- Significant reduction in available revolving credit facility ($5M reduction).
- Increased prepayment premiums and additional fees totaling $1.9 million paid to lenders.
- Delay of financial covenant testing (leverage and fixed charge coverage) until Dec 31, 2026, suggests difficulty meeting current terms.
- Massive workforce reduction (15%) indicating operational distress/restructuring.
📋 Key Facts
- Entered into Amendment No. 2 to Financing Agreement on Dec 15, 2025.
- Issued 'Penny Warrants' with an exercise price of $0.01 per share (totaling 1,750,129 shares immediately exercisable).
- Issued other warrants at $1.25 and $1.50 strike prices to induce lenders into the amendment.
- Reduced revolving credit facility availability by $5 million through Dec 31, 2026.
- Announced a 15% global workforce reduction as part of an organizational transformation plan.
- Estimated total restructuring charges of approximately $11 million to be recorded in FY2026.
Accuray Incorporated held its 2025 Annual Meeting of Stockholders on November 13, 2025. The meeting resulted in the election of three directors and the approval of several key shareholder proposals, including a new equity incentive plan.
📋 Key Facts
- Stockholders approved the Company's 2026 Equity Incentive Plan (Proposal No. 2).
- Three directors were elected to Class I: Anne B. Le Grand, Joseph E. Whitters, and Chan W. Galbato.
- Shareholders provided an advisory vote approving executive compensation (Say-on-Pay) (Proposal No. 3).
- Grant Thornton LLP was ratified as the independent registered public accounting firm for the fiscal year ending June 30, 2026 (Proposal No. 4).
Accuray Inc. has filed an 8-K to announce its fiscal 2026 first quarter financial results for the period ended September 30, 2025. The filing includes a press release and an investor presentation.
📋 Key Facts
- Reported date: November 5, 2025
- Reporting period: Fiscal 2026 First Quarter (ended September 30, 2025)
- Included Exhibit 99.1: Press release titled 'Accuray Reports Fiscal 2026 First Quarter Financial Results'
- Included Exhibit 99.2: Earnings call presentation for investors/analysts
- The information was furnished under Item 2.02 and Item 7.01, not filed for purposes of Section 18 liability.
Accuray Inc. announced significant leadership changes, including the appointment of Stephen La Neve as new CEO and a related-party consulting agreement with Dedication Capital, LLC (an affiliate of Board member Steven F. Mayer). The filing also includes preliminary Q1 2025 financial results.
🚩 Red Flags
- Related-party transaction: Consulting agreement with an affiliate of a Board member (Steven F. Mayer).
- Significant equity dilution potential: Large grants of RSUs/PSUs to both the new CEO and the related-party consultant.
- High performance-based incentive thresholds: Stock price targets for consultants and CEO extend out to 2031, suggesting current stock price is well below these levels.
📋 Key Facts
- Stephen La Neve appointed as President and CEO, succeeding Suzanne Winter who resigned effective Oct 19, 2025.
- New CEO compensation includes $750,000 base salary and significant equity awards (1.25M RSUs and 1.25M PSUs) tied to stock price performance through 2031.
- Entered into a consulting agreement with Dedication Capital, LLC (affiliate of Board member Steven F. Mayer) for 'Transformation Board Sponsor' services.
- Consulting agreement includes $600,000 annual base fee and up to $531,250 in cash incentives for FY2026.
- Dedication Capital/Mayer to receive 1.25M RSAs and 1.25M performance-based RSAs (PRSAs) tied to stock price targets ($2.00, $2.50, and $3.00).
- Preliminary Q1 2025 financial results were issued via press release on Oct 20, 2025.
Accuray Incorporated announced the departure of its Senior Vice President, Chief Legal Officer, and Corporate Secretary, Jesse Chew, effective September 19, 2025. The company has entered into a short-term consulting agreement with Mr. Chew to facilitate a smooth transition of his responsibilities.
🚩 Red Flags
- Departure of a key executive (Chief Legal Officer) can sometimes signal internal friction or regulatory concerns, though not explicitly stated here.
📋 Key Facts
- Jesse Chew departed from the role of SVP, CLO, and Corporate Secretary on September 19, 2025.
- A consulting agreement has been executed for the period of September 19, 2025, through December 31, 2025.
- The consultant will receive a monthly retainer of $20,000.
- Outstanding equity awards will continue to vest during the consultancy term.
Accuray Inc. announced the upcoming departure of a Class I director and the resignation of its Chief Legal Officer. Both departures are characterized as non-dispute related.
🚩 Red Flags
- Simultaneous departure of a director and the Chief Legal Officer (CLO) can sometimes signal internal shifts, though no disagreement was cited.
📋 Key Facts
- Director Robert C. Kill will not stand for re-election at the November 2025 Annual Meeting; he will remain on the Board/Compensation Committee until then.
- Jesse Chew, Senior Vice President, Chief Legal Officer and Corporate Secretary, is resigning effective September 19, 2025.
- Mr. Chew has agreed to a consulting arrangement through December 31, 2025.
- Both departures are explicitly stated as not being due to any disagreement with the Company or its Board.
Accuray Incorporated has filed an 8-K to announce its financial results for the fourth quarter and fiscal year ended June 30, 2025. The filing includes a press release and an investor presentation.
📋 Key Facts
- Reporting period: Fourth Quarter and Fiscal Year ended June 30, 2025.
- Filing date: August 13, 2025.
- The company issued Exhibit 99.1 (Press Release) and Exhibit 99.2 (Earnings Call Presentation).
- Information was furnished under Item 2.02 and Item 7.01 of Form 8-K.
Accuray Inc. has entered into a massive debt restructuring involving the exchange of $82 million in convertible notes for equity and cash, alongside securing $190 million in new high-interest secured financing from TCW Asset Management.
🚩 Red Flags
- Massive Dilution: Issuance of millions of shares via note exchange and 'Penny Warrants' ($0.01 strike price) will heavily dilute existing shareholders.
- High-Cost Debt: Interest rates (SOFR + 8.5%) are significantly higher than the previous 3.75% notes, indicating increased risk profile.
- Loss of Control: TCW has gained a board seat and observer rights as part of the financing agreement.
- Restrictive Covenants: New debt includes strict leverage, coverage, and liquidity covenants that limit operational flexibility.
📋 Key Facts
- Exchange Agreement: Exchanging ~$82M of 3.75% Convertible Senior Notes due 2026 for ~8.88M shares and ~$68.6M in cash.
- New Financing: Secured $150M term loan, $20M delayed draw, and $20M revolving credit facility from TCW Asset Management (Total $190M).
- Interest Rates: High-cost debt with SOFR + 8.50% or Base Rate + 7.50%, featuring a PIK (payment-in-kind) option.
- Governance Change: TCW has appointed Steven F. Mayer to the Board and secured two non-voting observer rights.
- Warrants Issued: Significant equity dilution via Premium Warrants (17.18M shares at $1.68) and Penny Warrants (6.25M shares at $0.01).
- Collateral: First-priority liens on substantially all assets of the Company and its subsidiaries.
Accuray Inc. filed an 8-K to announce its fiscal 2025 third quarter financial results for the period ended March 31, 2025. The filing includes a press release and an investor presentation.
📋 Key Facts
- Reported date: April 30, 2025
- Fiscal Period: Third Quarter ended March 31, 2025
- Included Exhibit 99.1: Press release titled 'Accuray Reports Fiscal 2025 Third Quarter Financial Results'
- Included Exhibit 99.2: Earnings Call Presentation for Q3 Fiscal 2025
Accuray Inc. announced the appointment of Leonel Peralta as Senior Vice President and Chief Operations Officer, effective February 3, 2025. The filing details his extensive background in medical technology leadership and outlines his compensation package.
📋 Key Facts
- Leonel Peralta appointed as SVP and COO effective Feb 3, 2025.
- Peralta previously held leadership roles at Siemens Healthineers (VP, Head of Global Operations) and Medtronic plc (VP, Global Operations).
- Annual base salary is set at $450,000.
- Sign-on bonus of $80,000 provided.
- Target annual cash incentive bonus is 60% of base salary; performance bonus up to $300,000 based on targets.
- Equity compensation includes RSUs with an aggregate value of $750,000 vesting over four years.
- Severance includes standard 'without cause' terms and enhanced 'double trigger' benefits in the event of a change in control.
Accuray Inc. filed an 8-K to announce its financial results for the second quarter of fiscal year 2025, which ended on December 31, 2024. The filing includes a press release and an investor presentation.
📋 Key Facts
- Reporting period: Second Quarter Fiscal 2025 (ended December 31, 2024).
- Filing date: February 5, 2025.
- The company released a press release titled 'Accuray Reports Fiscal 2025 Second Quarter Financial Results' (Exhibit 99.1).
- An investor presentation was provided to analysts and investors (Exhibit 99.2).
Accuray Incorporated announced the appointment of Leonel Peralta as Senior Vice President and Chief Operations Officer, effective February 3, 2025. This is a routine leadership transition announcement via Regulation FD disclosure.
📋 Key Facts
- Leonel Peralta appointed as Senior Vice President, Chief Operations Officer (COO).
- Effective date of appointment: February 3, 2025.
- Announcement made via press release on January 21, 2025.
Accuray Inc. announced the mutual agreement for Michael Hoge, Senior Vice President of Global Operations, to depart the company effective January 6, 2025. The departure is characterized as a mutual agreement and not due to any dispute with management or operations.
🚩 Red Flags
- Executive turnover in a key operational role (Global Operations) can lead to temporary leadership gaps during the search for a successor.
📋 Key Facts
- Michael Hoge (SVP, Global Operations) will depart effective January 6, 2025.
- Departure is by mutual agreement; no disputes reported regarding company operations or policies.
- Severance includes a lump sum of 12 months' base salary.
- Severance includes a prorated portion of the fiscal year 2025 bonus.
- Severance includes 12 months of COBRA health coverage reimbursement.
- Benefits are contingent upon the execution of a release of claims.
Accuray Incorporated held its 2024 Annual Meeting of Stockholders on November 21, 2024, where shareholders approved amendments to equity and stock purchase plans. Additionally, the company appointed Michael Murphy as Principal Accounting Officer, effective December 2, 2024.
📋 Key Facts
- Stockholders approved increasing the 2016 Equity Incentive Plan by 5,000,000 shares.
- Stockholders approved increasing the 2007 Employee Stock Purchase Plan by 2,500,000 shares.
- Michael Murphy appointed as Principal Accounting Officer, effective December 2, 2024; he previously served as VP, Corporate Controller at Accuray since October 2024.
- James M. Hindman and Suzanne Winter were elected as Class III directors.
- Grant Thornton LLP was ratified as the independent registered public accounting firm for fiscal year ending June 30, 2025.
Accuray Inc. filed an 8-K to announce its fiscal 2025 first quarter financial results for the period ended September 30, 2024. The filing includes a press release and an investor presentation.
📋 Key Facts
- Reporting date: November 6, 2024
- Fiscal Period: First Quarter of Fiscal Year 2025 (ended September 30, 2024)
- Included Exhibits: Press release (99.1) and Earnings Call Presentation (99.2)
Accuray Incorporated announced the appointment of Michael Murphy as the new Vice President, Corporate Controller on October 21, 2024.
📋 Key Facts
- Michael Murphy has been appointed to the role of Vice President, Corporate Controller.
- The announcement was made via press release dated October 21, 2024.
- The filing is a Regulation FD disclosure under Item 7.01.
Accuray Incorporated announced the return of CEO and President Suzanne Winter from her medical leave of absence, effective October 15, 2024. Sandeep Chalke will transition from interim CEO back to his role as Senior Vice President and Chief Commercial Officer.
📋 Key Facts
- Suzanne Winter reassumed duties as CEO and President on October 15, 2024.
- Sandeep Chalke concludes term as interim CEO; continues as SVP and Chief Commercial Officer.
- The return follows a period of medical leave for the CEO.
Accuray Incorporated entered into a Fourth Amendment to its Credit Agreement on September 12, 2024. The amendment modifies financial covenants and significantly reduces available revolving credit commitments.
🚩 Red Flags
- Significant reduction in liquidity access: Available revolving commitments are capped at $20 million, which may indicate tightening credit conditions or lender concern regarding cash runway.
- Introduction of a Minimum Liquidity covenant suggests lenders are imposing stricter controls to ensure the company maintains sufficient cash reserves.
📋 Key Facts
- Entered into the Fourth Amendment to Credit Agreement on September 12, 2024.
- Modifies Consolidated Fixed Charge Coverage Ratio and Consolidated Senior Net Leverage Ratio for Q1 fiscal year 2025.
- Addition of a new Minimum Liquidity covenant.
- Reduction of Available Revolving Commitments to a maximum of $20 million.
Accuray Inc. announced that CEO Suzanne Winter is taking a temporary medical leave of absence effective September 3, 2024. Chief Commercial Officer Sandeep Chalke has been appointed as interim CEO and principal executive officer.
🚩 Red Flags
- Sudden leadership transition due to medical leave can create short-term operational uncertainty.
- Interim leadership often signals a period of strategic pause or potential volatility in management direction.
📋 Key Facts
- CEO Suzanne Winter to take temporary medical leave starting September 3, 2024.
- Sandeep Chalke (current CCO) appointed as interim CEO and interim principal executive officer effective September 3, 2024.
- Interim CEO compensation includes an increased annual base salary and a target bonus opportunity of $725,000 and 100%, respectively, during the interim period.
- The appointment is governed by a letter agreement to be filed in the upcoming 10-Q for the period ending September 30, 2024.
Accuray Incorporated issued an 8-K to announce its financial results for the fourth quarter and fiscal year ended June 30, 2024. The filing includes a press release and an investor presentation.
📋 Key Facts
- Reporting period: Fourth Quarter and Fiscal Year ended June 30, 2024.
- Filing date: August 14, 2024.
- The company released its earnings via press release (Exhibit 99.1) and an investor presentation (Exhibit 99.2).
- Information was furnished under Item 2.02 and Item 7.01 of Form 8-K.
Accuray Inc. announced the resignation of its VP and Chief Accounting Officer, Gina Corradetti, effective May 17, 2024. The company has appointed CFO Ali Pervaiz to serve as interim principal accounting officer.
🚩 Red Flags
- Sudden departure of the Chief Accounting Officer (CAO) can sometimes precede financial scrutiny, though no restatement was mentioned here.
📋 Key Facts
- Gina Corradetti resigned as VP, Chief Accounting Officer and principal accounting officer on May 6, 2024.
- Resignation effective date is May 17, 2024.
- Ali Pervaiz (current SVP and CFO) appointed as interim principal accounting officer effective May 17, 2024.
- Interim appointment remains in effect until a permanent successor is named.
- Ali Pervaiz has no additional compensation for this interim role.
Accuray Incorporated entered into a Third Amendment to its Credit Agreement on April 25, 2024. The amendment allows the company to add back restructuring and severance charges from its November 2023 reduction-in-force to its Consolidated EBITDA calculations for specific periods through late 2024.
🚩 Red Flags
- Use of EBITDA add-backs for restructuring charges can be used to artificially inflate perceived profitability/covenant compliance.
- The need to amend credit agreements specifically to include one-time costs in EBITDA suggests tight financial covenants or pressure on debt ratios.
📋 Key Facts
- Entered into Third Amendment to Credit Agreement on April 25, 2024.
- Amendment permits add-back of restructuring/severance charges from Nov 2023 reduction-in-force to Consolidated EBITDA.
- Restructuring charge add-backs: up to $2,633,000 for TTM ending March 31, June 30, and Sept 30, 2024; $0 thereafter.
- Pro forma 'run rate' cost savings add-backs: up to $6,836,000 (Mar 2024), $3,798,000 (Jun 2024), and $760,000 (Sep 2024).
- Simultaneous announcement of Fiscal 2024 Third Quarter financial results on May 1, 2024.
Accuray Incorporated filed an 8-K to announce its financial results for the second quarter of fiscal year 2024, which ended December 31, 2023. The filing includes a press release and an investor presentation.
📋 Key Facts
- Report date: January 31, 2024
- Reporting period: Fiscal 2024 Second Quarter (ended Dec 31, 2023)
- Included Exhibit 99.1: Press release regarding financial results
- Included Exhibit 99.2: Earnings call presentation for analysts and investors